Using ROC curve analysis of scores in normal and cancer tissues (Figs 2A and 2B), 3.5 was determined as the cut-off value for distinguishing patients with CRC revealing a high (95 patients, 65.5%) or low (50 patients, 34.5%) level of FAM50A expression. The gene discussed is FAM50A; the disease is cancer.